DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 9,490.00
+30.00 (0.32%)
At close: Nov 13, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 174.83 billion as of November 13, 2026. It is the 23,193rd most valuable company in the world and the 878th biggest in South Korea. Its market cap has decreased by 40.20% in one year.
Market Cap
174.83B
Enterprise Value
274.33B
Revenue
148.75B
Global Rank
Country Rank
#878 South Korea
PE Ratio
38.25
ChartMarket Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 174.83B, an increase of 1,015.82%. That is a compound annual growth rate of 11.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 174.83B | -42.74% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 230.33B |
| Vivozon Pharmaceutical | 185.31B |
| GC WellBeing | 170.58B |
| HEM Pharma | 164.37B |
| CellBion | 160.93B |
| NOVAREX | 151.04B |
| Kyung Dong Pharmaceutical | 144.01B |
| PHARMARESEARCH BIO | 117.06B |